Trial Profile
Effect of ivabradine when given with dobutamine in patents with stable heart failure and cardiogenic shock.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Mar 2015
Price :
$35
*
At a glance
- Drugs Ivabradine (Primary) ; Dobutamine
- Indications Cardiogenic shock; Heart failure
- Focus Therapeutic Use
- 23 Mar 2015 New trial record